brexit_istock-531915594_altamira83
altamira83 / iStockphoto.com
23 July 2018Big Pharma

Parliament votes for UK to stay in EMA

The UK Parliament has voted in favour of the UK’s continued participation in the European Medicines Agency (EMA).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
16 July 2018   While the UK’s pharmaceutical and biotech industries have welcomed the government’s latest White Paper on Brexit, a number of uncertainties remain, according to lawyers.
Big Pharma
2 August 2018   The European Medicines Agency has announced plans to temporarily further scale back and suspend activities in order to cope with a more significant staff loss from the agency’s relocation than was originally expected.
Big Pharma
6 August 2018   The UK government today published four documents about how Brexit will impact the operations and regulatory status of life sciences companies.

More on this story

Big Pharma
16 July 2018   While the UK’s pharmaceutical and biotech industries have welcomed the government’s latest White Paper on Brexit, a number of uncertainties remain, according to lawyers.
Big Pharma
2 August 2018   The European Medicines Agency has announced plans to temporarily further scale back and suspend activities in order to cope with a more significant staff loss from the agency’s relocation than was originally expected.
Big Pharma
6 August 2018   The UK government today published four documents about how Brexit will impact the operations and regulatory status of life sciences companies.

More on this story

Big Pharma
16 July 2018   While the UK’s pharmaceutical and biotech industries have welcomed the government’s latest White Paper on Brexit, a number of uncertainties remain, according to lawyers.
Big Pharma
2 August 2018   The European Medicines Agency has announced plans to temporarily further scale back and suspend activities in order to cope with a more significant staff loss from the agency’s relocation than was originally expected.
Big Pharma
6 August 2018   The UK government today published four documents about how Brexit will impact the operations and regulatory status of life sciences companies.